165 related articles for article (PubMed ID: 199093)
1. Equine rhinopneumonitis virus (herpesvirus type 1): attenuation in stable monkey cell line.
Purdy CW; Ford SJ; Grant WF
Am J Vet Res; 1977 Aug; 38(8):1211-5. PubMed ID: 199093
[TBL] [Abstract][Full Text] [Related]
2. An equine herpesvirus type 1 recombinant with a deletion in the gE and gI genes is avirulent in young horses.
Matsumura T; Kondo T; Sugita S; Damiani AM; O'Callaghan DJ; Imagawa H
Virology; 1998 Mar; 242(1):68-79. PubMed ID: 9501037
[TBL] [Abstract][Full Text] [Related]
3. Immunologic relationships between equine herpesvirus type 1 (equine abortion virus) and type 4 (equine rhinopneumonitis virus).
Fitzpatrick DR; Studdert MJ
Am J Vet Res; 1984 Oct; 45(10):1947-52. PubMed ID: 6208822
[TBL] [Abstract][Full Text] [Related]
4. Equine herpesvirus infections in yearlings in South-East Queensland.
Diallo IS; Hewitson GR; de Jong A; Kelly MA; Wright DJ; Corney BG; Rodwell BJ
Arch Virol; 2008; 153(9):1643-9. PubMed ID: 18677574
[TBL] [Abstract][Full Text] [Related]
5. [Mutations in the US2 and glycoprotein B genes of the equine herpesvirus 1 vaccine strain RacH have no effects on its attenuation].
Neubauer A; Meindl A; Osterrieder N
Berl Munch Tierarztl Wochenschr; 1999 Sep; 112(9):351-4. PubMed ID: 10507185
[TBL] [Abstract][Full Text] [Related]
6. In vitro cytotoxicity of serum and peripheral blood leukocytes for equine herpesvirus type 1-infected target cells.
Wilks CR
Am J Vet Res; 1977 Jan; 38(1):117-21. PubMed ID: 189645
[TBL] [Abstract][Full Text] [Related]
7. The equine herpesvirus 1 IR6 protein influences virus growth at elevated temperature and is a major determinant of virulence.
Osterrieder N; Neubauer A; Brandmüller C; Kaaden OR; O'Callaghan DJ
Virology; 1996 Dec; 226(2):243-51. PubMed ID: 8955044
[TBL] [Abstract][Full Text] [Related]
8. One way protection between equid herpesvirus 1 and 4 in vivo.
Edington N; Bridges CG
Res Vet Sci; 1990 Mar; 48(2):235-9. PubMed ID: 2159176
[TBL] [Abstract][Full Text] [Related]
9. Innate immunity during Equid herpesvirus 1 (EHV-1) infection.
Bridges CG; Edington N
Clin Exp Immunol; 1986 Jul; 65(1):172-81. PubMed ID: 2431815
[TBL] [Abstract][Full Text] [Related]
10. Infection of peripheral blood mononuclear cells with neuropathogenic equine herpesvirus type-1 strain Ab4 reveals intact interferon-α induction and induces suppression of anti-inflammatory interleukin-10 responses in comparison to other viral strains.
Wagner B; Wimer C; Freer H; Osterrieder N; Erb HN
Vet Immunol Immunopathol; 2011 Sep; 143(1-2):116-24. PubMed ID: 21764140
[TBL] [Abstract][Full Text] [Related]
11. Serum antibody responses to equine herpesvirus 1 glycoprotein D in horses, pregnant mares and young foals.
Foote CE; Love DN; Gilkerson JR; Rota J; Trevor-Jones P; Ruitenberg KM; Wellington JE; Whalley JM
Vet Immunol Immunopathol; 2005 May; 105(1-2):47-57. PubMed ID: 15797474
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the efficacy of inactivated combination and modified-live virus vaccines against challenge infection with neuropathogenic equine herpesvirus type 1 (EHV-1).
Goodman LB; Wagner B; Flaminio MJ; Sussman KH; Metzger SM; Holland R; Osterrieder N
Vaccine; 2006 Apr; 24(17):3636-45. PubMed ID: 16513225
[TBL] [Abstract][Full Text] [Related]
13. Cell-mediated immunity evaluation in foals infected with virulent equine herpesvirus-1 by multi-parameter flow cytometry.
Platt R; Sponseller BA; Chiang YW; Roth JA
Vet Immunol Immunopathol; 2010 Jun; 135(3-4):275-81. PubMed ID: 20116862
[TBL] [Abstract][Full Text] [Related]
14. Use of DNA and recombinant canarypox viral (ALVAC) vectors for equine herpes virus vaccination.
Minke JM; Fischer L; Baudu P; Guigal PM; Sindle T; Mumford JA; Audonnet JC
Vet Immunol Immunopathol; 2006 May; 111(1-2):47-57. PubMed ID: 16580075
[TBL] [Abstract][Full Text] [Related]
15. Equine herpesvirus type-1 modulates CCL2, CCL3, CCL5, CXCL9, and CXCL10 chemokine expression.
Wimer CL; Damiani A; Osterrieder N; Wagner B
Vet Immunol Immunopathol; 2011 Apr; 140(3-4):266-74. PubMed ID: 21349590
[TBL] [Abstract][Full Text] [Related]
16. The mucosal humoral immune response of the horse to infective challenge and vaccination with equine herpesvirus-1 antigens.
Breathnach CC; Yeargan MR; Sheoran AS; Allen GP
Equine Vet J; 2001 Nov; 33(7):651-7. PubMed ID: 11770985
[TBL] [Abstract][Full Text] [Related]
17. Vaccination of pregnant ponies against equine rhinopneumonitis.
Crandell RA; Mock RE; Lock TF
Am J Vet Res; 1980 Jul; 41(7):994-6. PubMed ID: 6254412
[TBL] [Abstract][Full Text] [Related]
18. Pathogenic potential of equine alphaherpesviruses: the importance of the mononuclear cell compartment in disease outcome.
Osterrieder N; Van de Walle GR
Vet Microbiol; 2010 Jun; 143(1):21-8. PubMed ID: 20202764
[TBL] [Abstract][Full Text] [Related]
19. Application of a chemically inactivated, adjuvanted vaccine to control abortigenic infection of mares by equine herpesvirus I.
Bryans JT; Allen GP
Dev Biol Stand; 1982; 52():493-8. PubMed ID: 6299858
[TBL] [Abstract][Full Text] [Related]
20. Equine herpesviruses 1 (EHV-1) and 4 (EHV-4)--epidemiology, disease and immunoprophylaxis: a brief review.
Patel JR; Heldens J
Vet J; 2005 Jul; 170(1):14-23. PubMed ID: 15993786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
